Epidemiology of skin cancer based on Japan's National Cancer Registry 2016–2017
Dai Ogata(Unknown), Akira Kawai(NTT (Japan)), Eiji Nakano, Naoya Yamazaki(Tokyo National Hospital), Kenjiro Namikawa(Tokyo Metropolitan Komagome Hospital), Yosuke Uchitomi(Jikei University School of Medicine), Takahiro Higashi(Unknown), Maiko Fujimori(National Coalition for Cancer Survivorship)
Cited by 36
Related Papers
Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2018|1k
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
|Cancer Cell|2022|828